| 0 |
OSTEOPOROSIS POSTMENOPAUSAL |
1 |
0.0067 |
| 1 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 2 |
CARDIAC PACEMAKER REPLACEMENT |
1 |
0.0022 |
| 3 |
TONGUE PARALYSIS |
1 |
0.0014 |
| 4 |
AORTIC DISORDER |
1 |
0.0013 |
| 5 |
URETERIC STENOSIS |
1 |
0.0012 |
| 6 |
BURNS THIRD DEGREE |
1 |
0.0009 |
| 7 |
HYDROCELE |
1 |
0.0009 |
| 8 |
ORCHITIS |
1 |
0.0009 |
| 9 |
EPIDIDYMITIS |
1 |
0.0009 |
| 10 |
TESTICULAR SWELLING |
1 |
0.0008 |
| 11 |
DEAFNESS BILATERAL |
1 |
0.0006 |
| 12 |
URINARY BLADDER HAEMORRHAGE |
1 |
0.0005 |
| 13 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
1 |
0.0005 |
| 14 |
GASTROINTESTINAL ULCER |
1 |
0.0005 |
| 15 |
TESTICULAR PAIN |
1 |
0.0003 |
| 16 |
SUSPECTED COVID-19 |
1 |
0.0003 |
| 17 |
SKIN MASS |
2 |
0.0003 |
| 18 |
PROSTATOMEGALY |
1 |
0.0003 |
| 19 |
HYPERPHAGIA |
1 |
0.0003 |
| 20 |
TOOTH INJURY |
1 |
0.0002 |
| 21 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 22 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 23 |
MENISCUS INJURY |
1 |
0.0002 |
| 24 |
SWELLING OF EYELID |
1 |
0.0002 |
| 25 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 26 |
FORMICATION |
1 |
0.0001 |
| 27 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 28 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 29 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 30 |
BLADDER DISORDER |
1 |
0.0001 |
| 31 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 32 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 33 |
SKIN LACERATION |
1 |
0.0001 |
| 34 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 35 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 36 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 37 |
CYTOPENIA |
1 |
0.0001 |
| 38 |
HALLUCINATION |
6 |
0.0001 |
| 39 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 40 |
DELUSION |
1 |
0.0001 |
| 41 |
ABSCESS |
1 |
0.0001 |
| 42 |
BACK DISORDER |
1 |
0.0001 |
| 43 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 44 |
LOCAL SWELLING |
1 |
0.0001 |
| 45 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 46 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 47 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 48 |
PHOTOPHOBIA |
1 |
0.0001 |
| 49 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 50 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 51 |
HERNIA |
1 |
0.0001 |
| 52 |
ERUCTATION |
1 |
0.0001 |
| 53 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 54 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 55 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 56 |
SPINAL FRACTURE |
1 |
0.0000 |
| 57 |
TASTE DISORDER |
1 |
0.0000 |
| 58 |
DYSKINESIA |
2 |
0.0000 |
| 59 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 60 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 61 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 62 |
BALANCE DISORDER |
4 |
0.0000 |
| 63 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 64 |
LOCALISED INFECTION |
1 |
0.0000 |
| 65 |
HAEMATOMA |
1 |
0.0000 |
| 66 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 67 |
DIVERTICULITIS |
1 |
0.0000 |
| 68 |
DEMENTIA |
1 |
0.0000 |
| 69 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 70 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 71 |
EYE DISORDER |
1 |
0.0000 |
| 72 |
EYE PRURITUS |
1 |
0.0000 |
| 73 |
SINUSITIS |
3 |
0.0000 |
| 74 |
RASH MACULAR |
1 |
0.0000 |
| 75 |
MOBILITY DECREASED |
2 |
0.0000 |
| 76 |
DISORIENTATION |
1 |
0.0000 |
| 77 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 78 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 79 |
DRY MOUTH |
2 |
0.0000 |
| 80 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 81 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 82 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 83 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 84 |
CONTUSION |
2 |
0.0000 |
| 85 |
LUNG DISORDER |
1 |
0.0000 |
| 86 |
PRODUCT DOSE OMISSION ISSUE |
6 |
0.0000 |
| 87 |
DRY EYE |
1 |
0.0000 |
| 88 |
CELLULITIS |
1 |
0.0000 |
| 89 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 90 |
NERVOUSNESS |
1 |
0.0000 |
| 91 |
SPEECH DISORDER |
1 |
0.0000 |
| 92 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 93 |
RASH PRURITIC |
1 |
0.0000 |
| 94 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 95 |
NECK PAIN |
1 |
0.0000 |
| 96 |
PANCYTOPENIA |
1 |
0.0000 |
| 97 |
BLISTER |
1 |
0.0000 |
| 98 |
EYE PAIN |
1 |
0.0000 |
| 99 |
ASTHMA |
2 |
0.0000 |
| 100 |
EYE IRRITATION |
1 |
0.0000 |
| 101 |
DYSPHONIA |
1 |
0.0000 |
| 102 |
WHEEZING |
1 |
0.0000 |
| 103 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 104 |
IRRITABILITY |
1 |
0.0000 |
| 105 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 106 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 107 |
VERTIGO |
1 |
0.0000 |
| 108 |
DISCOMFORT |
1 |
0.0000 |
| 109 |
FEELING HOT |
1 |
0.0000 |
| 110 |
INJECTION SITE PAIN |
5 |
0.0000 |
| 111 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 112 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 113 |
AMNESIA |
1 |
0.0000 |
| 114 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 115 |
DEHYDRATION |
2 |
0.0000 |
| 116 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 117 |
HYPOTENSION |
3 |
0.0000 |
| 118 |
BRONCHITIS |
1 |
0.0000 |
| 119 |
EPISTAXIS |
1 |
0.0000 |
| 120 |
HOT FLUSH |
1 |
0.0000 |
| 121 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 122 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 123 |
TREMOR |
2 |
0.0000 |
| 124 |
FALL |
4 |
0.0000 |
| 125 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 126 |
TACHYCARDIA |
1 |
0.0000 |
| 127 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 128 |
ADVERSE EVENT |
1 |
0.0000 |
| 129 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 130 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 131 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 132 |
DYSPEPSIA |
1 |
0.0000 |
| 133 |
DIZZINESS |
5 |
0.0000 |
| 134 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 135 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 136 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 137 |
ILLNESS |
1 |
0.0000 |
| 138 |
HAEMORRHAGE |
1 |
0.0000 |
| 139 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 140 |
FATIGUE |
7 |
0.0000 |
| 141 |
SEPSIS |
1 |
0.0000 |
| 142 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 143 |
BACK PAIN |
2 |
0.0000 |
| 144 |
PALPITATIONS |
1 |
0.0000 |
| 145 |
CHILLS |
1 |
0.0000 |
| 146 |
FEELING ABNORMAL |
2 |
0.0000 |
| 147 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 148 |
PAIN |
5 |
0.0000 |
| 149 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 150 |
HYPERHIDROSIS |
1 |
0.0000 |
| 151 |
INSOMNIA |
2 |
0.0000 |
| 152 |
DRY SKIN |
1 |
0.0000 |
| 153 |
VISION BLURRED |
1 |
0.0000 |
| 154 |
COUGH |
2 |
0.0000 |
| 155 |
DYSPNOEA |
4 |
0.0000 |
| 156 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 157 |
DIARRHOEA |
4 |
0.0000 |
| 158 |
PNEUMONIA |
2 |
0.0000 |
| 159 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 160 |
COVID-19 |
1 |
0.0000 |
| 161 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 162 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 163 |
ASTHENIA |
2 |
0.0000 |
| 164 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 165 |
ERYTHEMA |
1 |
0.0000 |
| 166 |
HYPERTENSION |
1 |
0.0000 |
| 167 |
CONSTIPATION |
1 |
0.0000 |
| 168 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 169 |
WEIGHT INCREASED |
1 |
0.0000 |
| 170 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 171 |
DECREASED APPETITE |
1 |
0.0000 |
| 172 |
VOMITING |
2 |
0.0000 |
| 173 |
NAUSEA |
3 |
0.0000 |
| 174 |
WEIGHT DECREASED |
1 |
0.0000 |
| 175 |
DEATH |
3 |
0.0000 |
| 176 |
OFF LABEL USE |
3 |
0.0000 |
| 177 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 178 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 179 |
HEADACHE |
2 |
0.0000 |
| 180 |
PYREXIA |
1 |
0.0000 |
| 181 |
ARTHRALGIA |
1 |
0.0000 |
| 182 |
RASH |
1 |
0.0000 |
| 183 |
MALAISE |
1 |
0.0000 |